Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revising antimalarial drug policy in Central America: experience in Panama.

Transactions of the Royal Society of Tropical Medicine and Hygiene - 1 Jul 2008

Calzada Jose E, Samudio Franklyn, Bayard Vicente, Obaldia Nicanor, de Mosca Itza B, Pascale Juan M

Abstract excerpt

Panama is the first country in the Central American region that has officially discarded chloroquine as a first-line drug to treat Plasmodium falciparum cases. Here we describe the clinical and molecular findings from autochthonous P. falciparum fatal cases, and the epidemiological situation that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Chloroquine
Share to DNA, Protozoan

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatal Outcome

Share to Health Policy

Share to Malaria, Falciparum

Share to Panama

Share to Plasmodium falciparum

Source

Identifiers

PMID: 18436272
DOI: 10.1016/j.trstmh.2008.03.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18436272-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revising antimalarial drug policy in Central America: experience in Panama.PMID 18436272Read ↗

Prevalence of Plasmodium falciparum mutations associated with antimalarial drug resistance during an epidemic in Kuna Yala, Panama, Central America.Semantic proximity Read ↗

Clonal outbreak of Plasmodium falciparum infection in eastern Panama.Semantic proximity Read ↗

Population genomics of Plasmodium vivax in Panama to assess the risk of case importation on malaria eliminationSemantic proximity Read ↗

Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria.Semantic proximity Read ↗

Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos).Semantic proximity Read ↗

Prospects for malaria elimination in non-Amazonian regions of Latin America.Semantic proximity Read ↗

Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar.Semantic proximity Read ↗

Mutations in apicoplast rRNA genes are associated with clindamycin resistance and impair the ability of malaria parasites to infect mosquitoesSemantic proximity Read ↗

Mutations in apicoplast rRNA genes are associated with clindamycin resistance and impair the ability of malaria parasites to infect mosquitoes.Semantic proximity Read ↗

Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt.Semantic proximity Read ↗

In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.Semantic proximity Read ↗

Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.